Literature DB >> 11710994

Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response.

G W Warren1, P J van Ess, A M Watson, M P Mattson, R A Blouin.   

Abstract

Hepatic cytochrome P450 (CYP) expression and antioxidant activity have been shown to decrease following endotoxin (lipopolysaccharide [LPS]) or proinflammatory cytokine administration. Using mice deficient in interleukin-6 (IL-6), the role of IL-6 in the regulation of hepatic CYP activity, glutathione (GSH) metabolism, and catalase (CAT) activity was analyzed after LPS administration. Administration of LPS produced comparable decreases in hepatic CYP3A activity in WT B6x129 (WT) mice and IL-6 knockout mice. No decrease was observed for CYP2D9 activity after LPS administration in either WT or IL-6 knockout mice. LPS administration significantly increased hepatic and renal CYP2E1 and CYP4A activity in WT mice, with no effect in IL-6 knockout mice. CYP2A12 activity increased in IL-6 knockout, mice with no change in WT mice after LPS administration. LPS administration had no significant effect on hepatic GSH reductase, GST peroxidase, GSH-S-transferase (GST), or total GSH in either WT or IL-6 knockout. However, hepatic CAT activity was significantly reduced in WT mice after LPS administration, with no effect in IL-6 knockout mice. These results support IL-6 as a critical mediator of the effects of LPS on specific hepatic and renal CYP activities and hepatic CAT activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710994     DOI: 10.1089/107999001753238060

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  12 in total

Review 1.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

2.  Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes.

Authors:  Romi Ghose; Tao Guo; Jesus G Vallejo; Adarsh Gandhi
Journal:  Drug Metab Dispos       Date:  2011-02-08       Impact factor: 3.922

3.  Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice.

Authors:  Beatrice A Nyagode; Choon-Myung Lee; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2010-08-18       Impact factor: 4.030

4.  Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases.

Authors:  Li-Qun Yang; Shen-Jing Li; Yun-Fei Cao; Xiao-Bo Man; Wei-Feng Yu; Hong-Yang Wang; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

5.  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

Authors:  Sylvie M Mimche; Beatrice A Nyagode; Matthew D Merrell; Choon-Myung Lee; Nina S Prasanphanich; Richard D Cummings; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-10-25       Impact factor: 3.922

6.  Gender differences in murine pulmonary responses elicited by cellulose nanocrystals.

Authors:  Anna A Shvedova; Elena R Kisin; Naveena Yanamala; Mariana T Farcas; Autumn L Menas; Andrew Williams; Philip M Fournier; Jeffrey S Reynolds; Dmitriy W Gutkin; Alexander Star; Richard S Reiner; Sabina Halappanavar; Valerian E Kagan
Journal:  Part Fibre Toxicol       Date:  2016-06-08       Impact factor: 9.400

7.  Impact of phytosterols on liver and distal colon metabolome in experimental murine colitis model: an explorative study.

Authors:  Nunzia Iaccarino; Jussara Amato; Bruno Pagano; Anna Di Porzio; Matteo Micucci; Luca Bolelli; Rita Aldini; Ettore Novellino; Roberta Budriesi; Antonio Randazzo
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

8.  Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.

Authors:  Mahmoud A El-Ghiaty; Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

9.  Polysaccharides From Chrysanthemum morifolium Ramat Ameliorate Colitis Rats via Regulation of the Metabolic Profiling and NF-κ B/TLR4 and IL-6/JAK2/STAT3 Signaling Pathways.

Authors:  Jin-Hua Tao; Jin-Ao Duan; Wei Zhang; Shu Jiang; Jian-Ming Guo; Dan-Dan Wei
Journal:  Front Pharmacol       Date:  2018-07-10       Impact factor: 5.810

10.  Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content.

Authors:  Y Shirasaka; A S Chaudhry; M McDonald; B Prasad; T Wong; J C Calamia; A Fohner; T A Thornton; N Isoherranen; J D Unadkat; A E Rettie; E G Schuetz; K E Thummel
Journal:  Pharmacogenomics J       Date:  2015-09-01       Impact factor: 3.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.